BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 30985632)

  • 1. Efficacy and Safety of Single-Dose Oral Delafloxacin Compared With Intramuscular Ceftriaxone for Uncomplicated Gonorrhea Treatment: An Open-Label, Noninferiority, Phase 3, Multicenter, Randomized Study.
    Hook EW; Golden MR; Taylor SN; Henry E; Tseng C; Workowski KA; Swerdlow J; Nenninger A; Cammarata S
    Sex Transm Dis; 2019 May; 46(5):279-286. PubMed ID: 30985632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea.
    Taylor SN; Marrazzo J; Batteiger BE; Hook EW; Seña AC; Long J; Wierzbicki MR; Kwak H; Johnson SM; Lawrence K; Mueller J
    N Engl J Med; 2018 Nov; 379(19):1835-1845. PubMed ID: 30403954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea: A Phase 2, Randomized, Dose-Ranging, Single-Oral Dose Evaluation.
    Taylor SN; Morris DH; Avery AK; Workowski KA; Batteiger BE; Tiffany CA; Perry CR; Raychaudhuri A; Scangarella-Oman NE; Hossain M; Dumont EF
    Clin Infect Dis; 2018 Aug; 67(4):504-512. PubMed ID: 29617982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gentamicin 240 mg plus azithromycin 2 g vs. ceftriaxone 500 mg plus azithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea: a randomized controlled trial.
    Rob F; Klubalová B; Nyčová E; Hercogová J; Unemo M
    Clin Microbiol Infect; 2020 Feb; 26(2):207-212. PubMed ID: 31419483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea.
    Kirkcaldy RD; Weinstock HS; Moore PC; Philip SS; Wiesenfeld HC; Papp JR; Kerndt PR; Johnson S; Ghanem KG; Hook EW
    Clin Infect Dis; 2014 Oct; 59(8):1083-91. PubMed ID: 25031289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhoea (SOLITAIRE-U): a randomised phase 3 non-inferiority trial.
    Chen MY; McNulty A; Avery A; Whiley D; Tabrizi SN; Hardy D; Das AF; Nenninger A; Fairley CK; Hocking JS; Bradshaw CS; Donovan B; Howden BP; Oldach D;
    Lancet Infect Dis; 2019 Aug; 19(8):833-842. PubMed ID: 31196813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiological Analysis from a Phase 2 Randomized Study in Adults Evaluating Single Oral Doses of Gepotidacin in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria gonorrhoeae.
    Scangarella-Oman NE; Hossain M; Dixon PB; Ingraham K; Min S; Tiffany CA; Perry CR; Raychaudhuri A; Dumont EF; Huang J; Hook EW; Miller LA
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30249694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter trial of fleroxacin versus ceftriaxone in the treatment of uncomplicated gonorrhea.
    Smith BL; Mogabgab WJ; Dalu ZA; Jones RB; Douglas JM; Handsfield HH; Hook EW; Viner BL; Shands JW; McCormack WM
    Am J Med; 1993 Mar; 94(3A):81S-84S. PubMed ID: 8452187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of Neisseria gonorrhoeae DNA following treatment for pharyngeal and rectal gonorrhea is influenced by antibiotic susceptibility and reinfection.
    Bissessor M; Whiley DM; Fairley CK; Bradshaw CS; Lee DM; Snow AS; Lahra MM; Hocking JS; Chen MY
    Clin Infect Dis; 2015 Feb; 60(4):557-63. PubMed ID: 25371490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cephalosporin and azithromycin susceptibility in Neisseria gonorrhoeae isolates by site of infection, British Columbia, 2006 to 2011.
    Hottes TS; Lester RT; Hoang LM; McKay R; Imperial M; Gilbert M; Patrick D; Wong T; Martin I; Ogilvie G
    Sex Transm Dis; 2013 Jan; 40(1):46-51. PubMed ID: 23250301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized study of cefotaxime versus ceftriaxone for uncomplicated gonorrhea.
    Mogabgab WJ; Lutz FB
    South Med J; 1994 Apr; 87(4):461-4. PubMed ID: 8153771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of treatment with single-dose ampicillin/sulbactam with probenecid or ceftriaxone in patients with uncomplicated gonorrhea.
    Baddour LM; Busby L; Shapiro E; Cox KB; Glassco S; Johnson JK
    Sex Transm Dis; 1992; 19(6):341-5. PubMed ID: 1492262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-dose cefixime 800 mg plus doxycycline 100 mg twice a day for 7 days compared with single-dose ceftriaxone 1 g plus single-dose azithromycin 2 g for treatment of urogenital, rectal, and pharyngeal gonorrhoea: a randomised clinical trial.
    Bížová B; Procházka P; Nyčová E; Bořil P; Kubele J; Poláková A; Zemanová Z; Unemo M; Rob F
    Clin Microbiol Infect; 2024 Feb; 30(2):211-215. PubMed ID: 37981059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose oral temafloxacin versus parenteral ceftriaxone in the treatment of gonococcal urethritis/cervicitis.
    Mogabgab WJ
    Am J Med; 1991 Dec; 91(6A):145S-149S. PubMed ID: 1662885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of cefuroxime axetil and procaine penicillin in the treatment of uncomplicated gonorrhoea.
    Kinghorn GR; Spencer RC; Smith TK; Woolley PD; Patel R; Robinson AJ
    Int J STD AIDS; 1990 Jul; 1(4):285-7. PubMed ID: 2128472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of single-dose cefuroxime axetil with ciprofloxacin in treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase-producing Neisseria gonorrhoeae strains.
    Thorpe EM; Schwebke JR; Hook EW; Rompalo A; McCormack WM; Mussari KL; Giguere GC; Collins JJ
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2775-80. PubMed ID: 9124839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single dose 1 g ceftriaxone for urogenital and pharyngeal infection caused by Neisseria gonorrhoeae.
    Muratani T; Inatomi H; Ando Y; Kawai S; Akasaka S; Matsumoto T
    Int J Urol; 2008 Sep; 15(9):837-42. PubMed ID: 18665871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose cefixime versus single-dose ceftriaxone in the treatment of antimicrobial-resistant Neisseria gonorrhoeae infection.
    Plourde PJ; Tyndall M; Agoki E; Ombette J; Slaney LA; D'Costa LJ; Ndinya-Achola JO; Plummer FA
    J Infect Dis; 1992 Oct; 166(4):919-22. PubMed ID: 1527431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiological efficacy and tolerability of a single-dose regimen of 1 g of ceftriaxone in men with gonococcal urethritis.
    Ito S; Yasuda M; Hatazaki K; Mizutani K; Tsuchiya T; Yokoi S; Nakano M; Deguchi T
    J Antimicrob Chemother; 2016 Sep; 71(9):2559-62. PubMed ID: 27246232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose ciprofloxacin for the treatment of uncomplicated gonorrhea: a worldwide summary.
    Echols RM; Heyd A; O'Keeffe BJ; Schacht P
    Sex Transm Dis; 1994; 21(6):345-52. PubMed ID: 7871449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.